No increase of melanoma after kidney transplantation in the northern part of the Netherlands

Melanoma Research

Volumn 17, Issue 6, 2007, Pages 349-353

  Bastiaannet, Esther ^a   Homan Van Der Heide, Jaap J ^b   Ploeg, Rutger J ^b   Hoekstra, Harald J ^b  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Cancer after transplantation; Kidney; Melanoma; Renal transplantation; Transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MELANOMA; NETHERLANDS; PRIORITY JOURNAL; UNIVERSITY HOSPITAL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; MALE; MELANOMA; MIDDLE AGED; NETHERLANDS; PREVALENCE; SKIN NEOPLASMS;

EID: 36048967203     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e3282f0c880     Document Type: Article

References (29)

1. Moloney FJ, Comber H, O'Lorcain P, O'Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2005; 154:498.
2. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl 1998; 12:147.
3. Gooptu C, Woollons A, Ross J, Price M, Wojnarowska F, Morris PJ, et al. Merkel cell carcinoma arising after therapeutic immunosuppression. Br J Dermatol 1997; 137:637.
4. Sheil AG, Disney AP, Mathew TH, Amiss N. De-novo malignancy emerges as a major cause of morbidity and late failure in renal transplantation. Transplant Proc 1993; 25:1383.
5. Nafar M, Einollahi B, Hemati K, Gholi FP, Firouzan A. Development of malignancy following living donor kidney transplantation. Transplant Proc 2005; 37:3065.
6. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004; 4:905.
7. Boyle J, MacKie RM, Briggs JD, Junor BJ, Aitchison TC. Cancer, warts, and sunshine in renal transplant patients. A case-control study. Lancet 1984; 1:702.
8. Barr BB, Benton EC, McLaren K, Bunney MH, Smith IW, Blessing K, Hunter JA, et al. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet 1989; 2:224.
9. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B, et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61:715.
10. De Jong-Tieben LM, Berkhout RJ, Smits HL, Bouwes Bavinck JN, Vermeer BJ, van der Woude FJ, ter Schegget J. High frequency of detection of epidermodysplasia verruciformis-associated human papillomavirus DNA in biopsies from malignant and premalignant skin lesions from renal transplant recipients. J Invest Dermatol 1995; 105:367.
11. Lindelof B, Sigurgeirsson B, Gabel H, Stern RS. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513.
12. Sheil AGR. Cancer in dialysis and transplant patients. In: Morris PJ, editor. Kidney transplantation. Philadelphia: W.B. Saunders; 1989. p. 603.
13. Zimmerman SW, Esch J. Skin lesions treated with azathioprine and prednisone. Comparison of nontransplant patients and renal transplant recipients. Arch Intern Med 1978; 138:912.
14. Kinlen LJ. Incidence of cancer in rheumatoid arthritis and other disorders after immunosuppressive treatment. Am J Med 1985; 78:44.
15. Hollenbeak CS, Todd MM, Billingsley EM, Harper G, Dyer AM, Lengerich EJ. Increased incidence of melanoma in renal transplantation recipients. Cancer 2005; 104:1962.
16. Zimmerman SW, Esch J. Skin lesions treated with azathioprine and prednisone. Comparison of nontransplant patients and renal transplant recipients. Arch Intern Med 1978; 138:912.
17. Jensen P, Moller B, Hansen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 2000; 42:307.
18. Hartevelt MM, Bavinck JN, Kootte AM, Vermeer BJ, Vandenbroucke JP. Incidence of skin cancer after renal transplantation in The Netherlands. Transplantation 1990; 49:506.
19. Otley CC, Pittelkow MR. Skin cancer in liver transplant recipients. Liver Transpl 2000; 6:253.
20. Walder BK, Robertson MR, Jeremy D. Skin cancer and immunosuppression. Lancet 1971; 2:1282.
21. Marshall V. Premalignant and malignant skin tumours in immunosuppressed patients. Transplantation 1974; 17:272.
22. Sheil AG. Cancer in renal allograft recipients in Australia and New Zealand. Transplant Proc 1977; 9:1133.
23. Farzad Z, McBride W, Cochran AJ. Immunology of melanoma. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK, editors. Malignant melanoma: medical and surgical management. New York: McGraw-Hill; 1994. p. 27.
24. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal-transplant recipients. Lancet 1981; 1:1196.
25. Newstead CG. Assessment of risk of cancer after renal transplantation. Lancet 1998; 351:610.
26. Dantal J, Hourmant M, Cantarovich D, Giral M, Blancho G, Dreno B, Soulillou JP. Effect of long-term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporin regimens. Lancet 1998; 351:623.
27. Blohme I, Larko O. No difference in skin cancer incidence with or without cyclosporine: a 5-year perspective. Transplant Proc 1992; 24:313.
28. Bunney MH, Benton EC, Barr BB, Smith IW, Anderton JL, Hunter JA. The prevalence of skin disorders in renal allograft recipients receiving cyclosporin A compared with those receiving azathioprine. Nephrol Dial Transplant 1990; 5:379.
29. Bordea C, Wojnarowska F, Millard PR, Doll H, Welsh K, Morris PJ. Skin cancers in renal-transplant recipients occur more frequently than previously recognized in a temperate climate. Transplantation 2004; 77:574-579.